Michael Cloonan
CIK 1704336 · President & CEO · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.66M
Companies
3
Total Filings
19
Lifetime Open-Market Net
-$10.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SION | President & CEO | 547,343 | $35.92 | $19.66M | -$6.33M | 7 | 2026-01-06 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 0 | $4.97 | $0 | $0 | 3 | 2025-06-03 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Chief Business Officer | 3,190 | $8.68 | $27.7K | -$4.38M | 9 | 2021-02-12 |
Recent Filings · Page 2 of 2
19 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-12 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-05 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-30 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-14 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-29 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +1,362 | -$175.6K | EDGAR |
| 2019-05-24 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | — | -$2.54M | EDGAR |
| 2019-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-04 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-04 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.